Antiemetic Effect of Tetrahydrocannabinol
- 1 November 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 140 (11) , 1431-1433
- https://doi.org/10.1001/archinte.1980.00330220019010
Abstract
• Fifty-five patients harboring a variety of neoplasms and previously found to have severe nausea or emesis from antitumor drugs were given antiemetic prophylaxis in a double-blind, randomized, crossover fashion. Tetrahydrocannabinol (THC), prochlorperazine, and placebo were compared. Nausea was absent in 40 of 55 patients receiving THC, eight of 55 patients receiving prochlorperazine, and five of 55 in the placebo group. The antiemetic effect of THC appeared to be more efficacious for cyclophosphamide, fluorouracil, and doxorubicin hydrochloride, and less so for mechlorethamine hydrochloride and the nitrosureas. Tetrahydrocannabinol appears to offer significant control of nausea in most patients and exceeding by far that provided by prochlorperazine. (Arch Intern Med140:1431-1433, 1980)This publication has 4 references indexed in Scilit:
- Anti-Emetic Activity of Tetrahydrocannabinol in Rats and PigeonsNew England Journal of Medicine, 1978
- Tetrahydrocannabinol and ChemotherapyNew England Journal of Medicine, 1976
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1975
- Clinical and Psychological Effects of Marihuana in ManScience, 1968